中国公众合理用药援助系统
药品查询
请勾选查询条件后检索
药品名 企业名 批准文号 功能主治
你的位置:首页 > 药讯频道 > 药讯 > 学术科研 > 正文
高尿酸血症的研究进展
www.yongyao.net  2009-8-19 11:37:14  来源:  责任编辑:
分享到:

4 小 结

对HUA的流行现状的认识,人们会更加重视科学的行为和生活方式的科学化以预防HUA,关注HUA与疾病的高度相关性,将焦点集中到炎症、感染性疾病、心脑血管疾病、肾脏疾病、器官移植、肿瘤、机体亚健康状态以及心理状态等方面。HUA对脂质代谢、胰岛素抵抗、Na +代谢的影响,对血管及其内皮细胞的作用,致炎性及免疫反应的激活,参与氧化应激等,都将在疾病和健康的认识中产生巨大的影响。HUA很有可能成为心脑血管疾病、肾脏疾病、感染性疾病、器官移植并发症、肿瘤化疗以及亚健康状态、心理状态等健康和疾病状态评价、诊断、预防和治疗的重要指标。


参考文献
[ 1 ]  滕森新,郑洁(译) . 高尿酸血症[ J ]. 日本医学介绍, 2001, 22(7) : 3072309.
[ 2 ]  Lohsoonthorn V,Dhanamun B,WilliamsMA. Prevalence of hyperuricemia and its relationship with metabotic syndrome in Thai adults receiving annual health exams[ J ]. Arch Med Res, 2006, 37 ( 7) :8832889.
[ 3 ]  Maliavskaia SI, Lebedev AV, Ternovskaia VA. Chronic asymp tomatic hyperuricemia as a marker of atherogenic risk in children[ J ]. Kardiologiia, 2007, 47 (3) : 62266. .
[ 4 ]  方卫纲,黄晓明,王冠玉,等. 高尿酸血症在北京地区别1997人中的患病情况及相关因素分析[ J ]. 中华医学杂志, 2006, 86(25) : 176421768.
[ 5 ]  徐俊文,陆锦波,张小娟,等. 佛山地区13324例居民血尿酸水平及相关指标分析[ J ]. 中国中西医结合杂志, 2005, 6 ( 7 ) :4012403.
[ 6 ]  古萍. 广州市体检人群高尿酸血症患病情况及相关疾病分析[ J ]. 中国热带医学, 2006, 6 (6) : 108221084.
[ 7 ]  Chien KL, Hsu HC, Sung FC, et al. Hyperuricemia as a risk factor on cardiovascular events in Taiwan: The Chin2Shan Community Cardiovascular Cohort Study [ J ]. Atherosclerosis, 2005, 183 ( 1 ) :1472155.
[ 8 ]  Lin KC,Lin HY, Chou P. Community based ep idemiological study on hyperuricemia and gout in Kin2Hu, Kinmen[ J ]. J Rheumatol,2000, 27 (4) : 104521050.
[ 9 ]  Choi HK, Ford ES. Prevalence of the metabolic syndrome in individuals with hyperuricemia [ J ]. Am J Med, 2007, 120 ( 5 ) :4422447.
[ 10 ]  Tsouli SG, Liberopoulos EN,Mikhailidis DP, et al. Elevated serumuric acid levels in metabolic syndrome: an active component or aninnocent bystander? [ J ]. Metabolism, 2006, 55 (10) : 129321301.
[ 11 ]  FeigD I, Johnson RJ. The role of uric acid in pediatric hypertension[ J ]. J Ren Nutr, 2007, 17 (1) : 79283.
[ 12 ]  Sanchez2Lozada LG, Tap ia E, Lopez2Molina R, et al. Effects of acute and chronic L2arginine treatmentin experimental hyperuricemia [ J ]. Am J Physiol Rena Physiol, 2007, 292 ( 4 ) :F12382F1244.
[ 13 ]  Baker JF, Krishnan E, Chen L, et al. Serum uric acid and cardiovascular disease: recent developments, and where do they leave us[ J ]. Am J Med, 2005, 118 (8) : 8162826.
[ 14 ]  Homayounfar S,AnsariM, Kashani KM. Evaluation of independentp rognostic importance of hyperuricemia in hosp ital death after acute myocardial infarction[ J ]. SaudiMed J, 2007, 28 (5) : 7592761.
[ 15 ]  Patschan D, Patschan S, Gobe GG, et al. Uric acid heralds ischemic tissue injury to mobilize endothelial p rogenitor cells[ J ]. J Am SocNephrol, 2007, 18 (5) : 151621524.
[ 16 ]  BenjellounM, Tarrass F, Hachim K, et al. Chronic lead poisoning:a forgotten cause of renal disease [ J ]. Saudi J Kidney DisTransp l, 2007, 18 (1) : 83286.
[ 17 ]  Roncal CA,Mu W, Croker B, et al. Effect of elevated serum uricacid on cisp latin2induced acute renal failure[ J ]. Am J Physiol Renal Physiol, 2007, 292 (1) : F1162F122.
[ 18 ]  Sood AR,BurryLD, ChengDK. Clarifying the role of rasburicase intumor lysis syndrome [ J ]. Pharmacotherapy, 2007, 27 ( 1 ) :1112121.
[ 19 ]  Chuang CC, Shiesh SC, Chi CH, et al. Serum total antioxidant capacity reflects severity of illness in patientswith severe sep sis[ J ].Crit Care, 2006, 10 (1) : R36.
[ 20 ]  KittlesonMM,Bead V, FradleyM, et al. E levated uric acid levelsp redict allograft vasculopathy in cardiac transp lant recip ients[ J ]. JHeart Lung Transp lant, 2007, 26 (5) : 4982503.
[ 21 ]  Plywaczewski R, Bednarek M, Jonczak L, et al. Hyperuricemia in femaleswith sleep apnoea [ J ]. Pneumonol Alorgol Pol, 2006, 74(2) : 1592165.
[ 22 ]  So A. Recent advances in the pathophysiology of hyperuricemia and gout[ J ]. RevMed Suisse, 2007, 3 (103) : 7222724.
[ 23 ]  Giovannini I, Chiarla C, Giuliante F, et al. Serum uric acid, creatinine, and the assessment of antioxidant capacity in critical illness[ J ]. Crit Care, 2006, 10 (5) : 4212423.
[ 24 ]  Cheung KJ, Tzameli I, Pissios P, et al. Xanthine oxidoreductase is aregulator of adipogenesis and PPARgamma activity [ J ]. CellMetab, 2007, 5 (2) : 1152128.
[ 25 ]  Sautin YY, Nakagawa T, Zharikov S, et al. Adverse effects of the classical antioxidant uric acid in adipocytesNADPH oxidase2mediated oxidative /nitrosative stress [ J ]. Am J Physiol Cell Physiol,2007, 293 (2) : C5842C596


来源:医学综述  作者:蒋光荣 郑恒 邵少慰

免责声明:本文仅代表作者个人观点,与本网无关。转载目的在于传递更多信息,并不代表本网赞同其观点和对其真实性负责。对本文以及其中全部或者部分内容、文字的真实性、完整性、及时性本站不作任何保证或承诺,请读者仅作参考,并请自行核实相关内容。
返回资讯中心 返回资讯列表